{"component": "definition", "props": {"groups": [{"samples": [{"hash": "hZZZqkVIVYF", "uri": "/contracts/hZZZqkVIVYF#janus", "label": "Fund Participation Agreement (Ids Life of New York Flexible Portfolio Annuity Account)", "score": 16.0, "published": true}, {"hash": "7fpuSP3P6c0", "uri": "/contracts/7fpuSP3P6c0#janus", "label": "Fund Participation Agreement (Valley Forge Life Insurance Co)", "score": 16.0, "published": true}, {"hash": "7MIDY3eci5U", "uri": "/contracts/7MIDY3eci5U#janus", "label": "Fund Participation Agreement (Ids Life Variable Account 10)", "score": 16.0, "published": true}], "snippet": "and that all use of \u2587\u2587\u2587 d\u2587\u2587\u2587\u2587\u2587ation comprised in whole or part of Janus (a \"Janus Mark\") under this Agre\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587l inure to the benefit of Janus Capital. Except as provided in Section 2.5, the Company shall not use any Janus Mark on its own behalf \u2587\u2587 \u2587\u2587 \u2587\u2587\u2587alf of the Accounts or Contracts in any registration statement, advertisement, sales literature or other materials relating to the Accounts or Contracts without the prior written consent of Janus Capital. Upon termination of this Agreement for any reason, the Company shall cease all use of any Janus Mark(s) as soon as reasona\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587cable.", "snippet_links": [{"key": "use-of-\u2587", "type": "clause", "offset": [13, 21]}, {"key": "inure-to-the-benefit", "type": "clause", "offset": [116, 136]}, {"key": "the-company-shall", "type": "clause", "offset": [190, 207]}, {"key": "the-accounts", "type": "clause", "offset": [265, 277]}, {"key": "any-registration-statement", "type": "definition", "offset": [294, 320]}, {"key": "sales-literature", "type": "definition", "offset": [337, 353]}, {"key": "other-materials", "type": "definition", "offset": [357, 372]}, {"key": "relating-to", "type": "definition", "offset": [373, 384]}, {"key": "consent-of", "type": "clause", "offset": [437, 447]}, {"key": "for-any-reason", "type": "clause", "offset": [498, 512]}], "size": 12, "hash": "de5121b745b0a8ab956b366b20ae7ea1", "id": 1}, {"samples": [{"hash": "8NhKJLEaYrC", "uri": "/contracts/8NhKJLEaYrC#janus", "label": "Investors\u2019 Rights Agreement (Janux Therapeutics, Inc.)", "score": 32.4305270363, "published": true}, {"hash": "2Wd2TkXvypK", "uri": "/contracts/2Wd2TkXvypK#janus", "label": "Investors\u2019 Rights Agreement (Janux Therapeutics, Inc.)", "score": 32.3785078713, "published": true}], "snippet": "means \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Biotech Innovation Master Fund Limited, \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Horizon Fund\u2014Biotechnology Fund, \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Global Life Sciences Fund and \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Capital Funds Plc\u2014\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Global Life Sciences Fund (each, together with its (i) permitted transferees and (ii) other entities under management by Janus Capital Management LLC, a \u201cJanus Investor\u201d).", "snippet_links": [{"key": "master-fund", "type": "definition", "offset": [41, 52]}, {"key": "life-sciences", "type": "definition", "offset": [134, 147]}, {"key": "capital-funds", "type": "definition", "offset": [173, 186]}, {"key": "permitted-transferees", "type": "clause", "offset": [262, 283]}, {"key": "other-entities", "type": "definition", "offset": [293, 307]}, {"key": "janus-capital-management-llc", "type": "definition", "offset": [328, 356]}], "size": 6, "hash": "4bdf08ea2defa4dc1eace95cef4031ae", "id": 2}, {"samples": [{"hash": "kNrLHo07BcI", "uri": "/contracts/kNrLHo07BcI#janus", "label": "Fund Participation Agreement (FSL Separate Account M)", "score": 16.0, "published": true}], "snippet": "and that all use of \u2587\u2587\u2587 d\u2587\u2587\u2587\u2587\u2587ation comprised in whole or part of Janus (a \"Janus Mark\") under this Agreeme\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 inure to the benefit of Janus Capital. Except as provided in Section 2.5, the Company shall not use any Janus Mark on its own behalf or \u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 of the Accounts or Contracts in any registration statement, advertisement, sales literature or other materials relating to the Accounts or Contracts without the prior written consent of Janus Capital. All references contained in this Agreement to \"the name or mark `Janus'\" shall include b\u2587\u2587 \u2587ot \u2587\u2587 limited to the Janus logo, the website www.janus.com and any and all e\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587nks relating to such website. The Company will make no use of the name or mark \"Janus\" except as expre\u2587\u2587\u2587\u2587 pr\u2587\u2587\u2587\u2587\u2587d in this Agreement or expressly authorized by Janus Capital in writing. All goodwill associated with the name and mark \"Janus\" shall inure to t\u2587\u2587 \u2587ene\u2587\u2587\u2587 \u2587f Janus Capital or its affiliates. Upon termination of this Agreement for any reason, the Company shall cease any and all use of any Janus Mark(s) as soon as reasona\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587cable.", "snippet_links": [{"key": "use-of-\u2587", "type": "clause", "offset": [13, 21]}, {"key": "inure-to-the-benefit", "type": "clause", "offset": [116, 136]}, {"key": "the-company-shall", "type": "clause", "offset": [190, 207]}, {"key": "the-accounts", "type": "clause", "offset": [265, 277]}, {"key": "any-registration-statement", "type": "definition", "offset": [294, 320]}, {"key": "sales-literature", "type": "definition", "offset": [337, 353]}, {"key": "other-materials", "type": "definition", "offset": [357, 372]}, {"key": "relating-to", "type": "definition", "offset": [373, 384]}, {"key": "consent-of", "type": "clause", "offset": [437, 447]}, {"key": "agreement-to", "type": "clause", "offset": [496, 508]}, {"key": "the-website", "type": "clause", "offset": [588, 599]}, {"key": "all-e", "type": "clause", "offset": [626, 631]}, {"key": "the-company-will", "type": "clause", "offset": [673, 689]}, {"key": "agreement-or", "type": "definition", "offset": [767, 779]}, {"key": "authorized-by", "type": "definition", "offset": [790, 803]}, {"key": "in-writing", "type": "definition", "offset": [818, 828]}, {"key": "associated-with", "type": "definition", "offset": [843, 858]}, {"key": "for-any-reason", "type": "clause", "offset": [983, 997]}], "size": 6, "hash": "8968593aa8de533cfa9bb143dc055466", "id": 3}, {"samples": [{"hash": "i6FVDKLDdpZ", "uri": "/contracts/i6FVDKLDdpZ#janus", "label": "Sub Investment Advisory Agreement (Northwestern Mutual Series Fund Inc)", "score": 16.0, "published": true}, {"hash": "X1SjMni4K1", "uri": "/contracts/X1SjMni4K1#janus", "label": "Sub Investment Advisory Agreement (Hartford HLS Series Fund Ii Inc)", "score": 16.0, "published": true}, {"hash": "7L4d3P1MqDJ", "uri": "/contracts/7L4d3P1MqDJ#janus", "label": "Sub Management Agreement (Hartford HLS Series Fund Ii Inc)", "score": 16.0, "published": true}], "snippet": "shall inure to the benefit of JCM or its affiliates. Upon termination of this Agreement for any reason, Investment Manager shall immediately cease, and Investment Manager shall cause the Portfolio to immediately cease any and all use of any \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587(s).", "snippet_links": [{"key": "inure-to-the-benefit", "type": "clause", "offset": [6, 26]}, {"key": "for-any-reason", "type": "clause", "offset": [88, 102]}, {"key": "investment-manager", "type": "definition", "offset": [104, 122]}, {"key": "the-portfolio", "type": "clause", "offset": [183, 196]}], "size": 5, "hash": "714ae5a3cdebc50f9f17553512a9b252", "id": 4}, {"samples": [{"hash": "g1oQ3Wftbyz", "uri": "https://ir.janusintl.com/sec-filings/all-sec-filings/content/0001193125-21-107542/0001193125-21-107542.pdf", "label": "Amendment", "score": 20.2307702531, "published": false}, {"hash": "eaA4D2BLCw5", "uri": "https://ir.janusintl.com/sec-filings/all-sec-filings/content/0001193125-21-130248/0001193125-21-130248.pdf", "label": "Amendment", "score": 20.1994952012, "published": false}, {"hash": "2pTvaq4knTV", "uri": "https://ir.janusintl.com/financial-information/sec-filings/content/0001193125-21-089681/0001193125-21-089681.pdf", "label": "Amendment", "score": 14.7152635181, "published": false}], "snippet": "means, collectively, Janus International Group, LLC, a Delaware limited liability company, and each of its operating subsidiaries. \u201cJBI\u201d means J.B.I., LLC, a Georgia limited liability company.", "snippet_links": [{"key": "international-group", "type": "definition", "offset": [27, 46]}, {"key": "a-delaware-limited-liability-company", "type": "clause", "offset": [53, 89]}, {"key": "operating-subsidiaries", "type": "definition", "offset": [107, 129]}, {"key": "georgia-limited-liability-company", "type": "clause", "offset": [158, 191]}], "size": 4, "hash": "ca7ef51ea299b0bb403f3591ad2c06eb", "id": 5}, {"samples": [{"hash": "lfkl9NN9vgu", "uri": "/contracts/lfkl9NN9vgu#janus", "label": "364 Day Competitive Advance and Revolving Credit Facility Agreement (Kansas City Southern Industries Inc)", "score": 18.0, "published": true}, {"hash": "aPBBGUl6a0s", "uri": "/contracts/aPBBGUl6a0s#janus", "label": "Credit Facility Agreement (Kansas City Southern Industries Inc)", "score": 18.0, "published": true}, {"hash": "5Lak9sOHd2z", "uri": "/contracts/5Lak9sOHd2z#janus", "label": "Competitive Advance and Revolving Credit Facility Agreement (Stilwell Financial Inc)", "score": 18.0, "published": true}], "snippet": "means Janus Capital Corporation, a Colorado corporation.", "snippet_links": [{"key": "janus-capital-corporation", "type": "definition", "offset": [6, 31]}], "size": 3, "hash": "bd91b7380a1acc1e1fef90f144f146e8", "id": 6}, {"samples": [{"hash": "4Kuz5G4fyI6", "uri": "https://ir.janusintl.com/sec-filings/all-sec-filings/content/0001193125-21-217695/0001193125-21-217695.pdf", "label": "Amendment", "score": 20.389606437, "published": false}, {"hash": "Ps5Eo3LgCo", "uri": "https://ir.janusintl.com/sec-filings/all-sec-filings/content/0001193125-21-239446/0001193125-21-239446.pdf", "label": "ir.janusintl.com", "score": 16.4842739711, "published": false}, {"hash": "8e8WxjlSX7y", "uri": "https://ir.janusintl.com/sec-filings/all-sec-filings/content/0001193125-21-209010/0001193125-21-209010.pdf", "label": "ir.janusintl.com", "score": 16.3135026427, "published": false}], "snippet": "\u201cwe,\u201d \u201cus,\u201d or the \u201cCompany\u201d means, collectively, Janus International Group, Inc., a Delaware corporation, and each of its operating subsidiaries from and after the Closing of the Transactions.", "snippet_links": [{"key": "international-group", "type": "definition", "offset": [56, 75]}, {"key": "delaware-corporation", "type": "clause", "offset": [85, 105]}, {"key": "operating-subsidiaries", "type": "definition", "offset": [123, 145]}, {"key": "closing-of-the-transactions", "type": "clause", "offset": [165, 192]}], "size": 3, "hash": "c4e0548846236ab53f5a0bc69a21a75f", "id": 7}, {"samples": [{"hash": "dPSeGTCSTzw", "uri": "/contracts/dPSeGTCSTzw#janus", "label": "Investors\u2019 Rights Agreement (MedicaMetrix, Inc/De)", "score": 32.7015742642, "published": true}, {"hash": "3lgRT8xP8w8", "uri": "/contracts/3lgRT8xP8w8#janus", "label": "Investors\u2019 Rights Agreement (MedicaMetrix, Inc/De)", "score": 32.5564681725, "published": true}, {"hash": "3NZXFp7pCyY", "uri": "/contracts/3NZXFp7pCyY#janus", "label": "Investors\u2019 Rights Agreement (MedicaMetrix, Inc/De)", "score": 32.4715947981, "published": true}], "snippet": "means Janus Capital Management, in its capacity as investment advisor to one or more Investors.", "snippet_links": [{"key": "capital-management", "type": "clause", "offset": [12, 30]}, {"key": "investment-advisor", "type": "definition", "offset": [51, 69]}], "size": 3, "hash": "2d7be0940b4549ac7ccb310539cb1004", "id": 8}, {"samples": [{"hash": "5pfmv085sVM", "uri": "/contracts/5pfmv085sVM#janus", "label": "Registration Rights Agreement (Silk Road Medical Inc)", "score": 30.5934291581, "published": true}, {"hash": "znAwxGnV2L", "uri": "/contracts/znAwxGnV2L#janus", "label": "Registration Rights Agreement (Silk Road Medical Inc)", "score": 30.1690622861, "published": true}, {"hash": "8Jw7l8cEe3E", "uri": "/contracts/8Jw7l8cEe3E#janus", "label": "Registration Rights Agreement (Silk Road Medical Inc)", "score": 29.9637234771, "published": true}], "snippet": "means \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Global Life Sciences Fund and Janus Capital Funds PLC on Behalf of its Series Janus Global Life Sciences Fund and their Affiliates.", "snippet_links": [{"key": "life-sciences", "type": "definition", "offset": [29, 42]}, {"key": "capital-funds", "type": "definition", "offset": [58, 71]}, {"key": "on-behalf-of", "type": "clause", "offset": [76, 88]}], "size": 3, "hash": "3e40f8f6969c55cf093c1aa95f7959f3", "id": 9}, {"samples": [{"hash": "fKguaBkHGVj", "uri": "/contracts/fKguaBkHGVj#janus", "label": "Investors\u2019 Rights Agreement (CARGO Therapeutics, Inc.)", "score": 34.8453114305, "published": true}, {"hash": "lntSJNigCXn", "uri": "/contracts/lntSJNigCXn#janus", "label": "Investors\u2019 Rights Agreement (CARGO Therapeutics, Inc.)", "score": 34.7987679671, "published": true}], "snippet": "means, together with its Affiliates, \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 Biotech Innovation Master Fund Limited.", "snippet_links": [{"key": "master-fund", "type": "definition", "offset": [72, 83]}], "size": 3, "hash": "d9fc2b354043c25e1f56ea8f11feda5a", "id": 10}], "next_curs": "ClISTGoVc35sYXdpbnNpZGVyY29udHJhY3Rzci4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIOamFudXMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "and that all use of \u2587\u2587\u2587 d\u2587\u2587\u2587\u2587\u2587ation comprised in whole or part of Janus (a \"Janus Mark\") under this Agre\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587l inure to the benefit of Janus Capital. Except as provided in Section 2.5, the Company shall not use any Janus Mark on its own behalf \u2587\u2587 \u2587\u2587 \u2587\u2587\u2587alf of the Accounts or Contracts in any registration statement, advertisement, sales literature or other materials relating to the Accounts or Contracts without the prior written consent of Janus Capital. Upon termination of this Agreement for any reason, the Company shall cease all use of any Janus Mark(s) as soon as reasona\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587cable.", "title": "Janus", "size": 70, "id": "janus", "examples": [], "related": [["insight", "Insight", "Insight"], ["blackrock", "BlackRock", "BlackRock"], ["alliancebernstein", "AllianceBernstein", "AllianceBernstein"], ["chs", "CHS", "CHS"], ["merc", "MERC", "MERC"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}